MDA Pharmaceuticals will now be known as Juno Pharmaceuticals. Stay tuned for our new website coming soon!
MDA Pharmaceuticals was founded in 2009 and is a member of the JUNO Pharmaceutical group. MDA Pharmaceuticals continues to invest heavily in business development and is now emerging as a leading Canadian supplier of generic products focused in the hospital and specialty care market. Our current product portfolio is continuing to expand and promotes niche generic molecules with a well targeted pipeline of products near patent expiry.